Observational Study on the Impact of Initiating Tiotropium Alone Versus Tiotropium with Fluticasone Propionate/Salmeterol Combination Therapy on Outcomes and Costs in Chronic Obstructive Pulmonary Disease-Reference-Cited by-同舟云学术

Observational Study on the Impact of Initiating Tiotropium Alone Versus Tiotropium with Fluticasone Propionate/Salmeterol Combination Therapy on Outcomes and Costs in Chronic Obstructive Pulmonary Disease

Published:2012 Issue:1 Volume:13 Page:15
ISSN:1465-9921
Container-title:Respiratory Research
language:en
Short-container-title:Respiratory Research

Author:

Chatterjee Arjun,Shah Manan,D'Souza Anna O,Bechtel Benno,Crater Glenn,Dalal Anand A

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-life therapeutic effects of beclomethasone dipropionate/formoterol fumarate/glycopyrronium combined triple therapy in patients with chronic obstructive pulmonary disease;Therapeutic Advances in Respiratory Disease;2023-01

2. State-of-the-art review of the application and development of various methods of aerosol therapy;International Journal of Pharmaceutics;2022-02

3. Real-world effectiveness of early intervention with fixed-dose tiotropium/olodaterol vs tiotropium in Japanese patients with COPD: a high-dimensional propensity score–matched cohort analysis;Respiratory Research;2021-06-17

4. Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD;npj Primary Care Respiratory Medicine;2021-05-25

5. Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease;Respiration;2020-12-10